Please enable JavaScript to continue using this application.

Compare $MGNX vs $TLSI | Chartloom

Compare

$MGNX vs $TLSI

MacroGenics Inc · TriSalus Life Sciences Inc

MGNX

MacroGenics Inc

TLSI

TriSalus Life Sciences Inc

Compare $MGNX vs $TLSI

Comparing MacroGenics Inc and TriSalus Life Sciences Inc

MGNXMacroGenics Inc

TLSITriSalus Life Sciences Inc

MGNXMacroGenics Inc

Market cap

$238M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.39x

Rev growth (TTM)

1.3%

YTD performance

132.3%

52W performance

110.1%

FCF yield

-27.6%

TLSITriSalus Life Sciences Inc

Market cap

$249M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.61x

Rev growth (TTM)

25.2%

YTD performance

-33.4%

52W performance

-16.3%

FCF yield

-9.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MGNX

TLSI

Detailed metrics comparison

MGNX

MacroGenics Inc

TLSI

TriSalus Life Sciences Inc

Market Cap

MGNX$238M

TLSI$249M

Enterprise Value

MGNX$302M

TLSI$236M

Price

MGNX$3.74

TLSI$4.06

P/E Ratio

MGNXN/A

TLSIN/A

P/S Ratio

MGNX1.42x

TLSI5.53x

EV/Sales

MGNX1.80x

TLSI5.24x

EV/EBITDA

MGNX5.31x

TLSI0.00x

P/B Ratio

MGNX5.32x

TLSI40.61x

P/FCF Ratio

MGNXN/A

TLSIN/A

EV/FCF

MGNX-4.61x

TLSI-10.14x

PEG Ratio

MGNXN/A

TLSIN/A

Forward P/E (NTM)

MGNXN/A

TLSIN/A

Forward P/S (NTM)

MGNX2.39x

TLSI3.61x

Revenue (TTM)

MGNX$168M

TLSI$45M

Revenue Growth (YoY)

MGNX1.3%

TLSI25.2%

Forward Rev Growth

MGNX-12.8%

TLSI40.1%

Gross Margin (TTM)

MGNX61.8%

TLSI85.8%

Operating Margin (TTM)

MGNX0.0%

TLSI0.0%

EBITDA Margin (TTM)

MGNX-20.8%

TLSI-66.4%

Net Margin (TTM)

MGNX-8.7%

TLSI-130.2%

FCF Margin (TTM)

MGNX-39.1%

TLSI-51.6%

Net Income (TTM)

MGNX$-15M

TLSI$-59M

FCF (TTM)

MGNX$-66M

TLSI$-23M

EPS (TTM)

MGNX-$0.23

TLSI-$1.01

ROE (TTM)

MGNX-3127.0%

TLSI-7902.0%

ROA (TTM)

MGNX-535.0%

TLSI-5499.0%

ROIC (TTM)

MGNX-1017.0%

TLSI-1789.0%

Cash

MGNX$114M

TLSI$46M

Debt

MGNX$178M

TLSI$33M

Net Cash/Debt

MGNX$-64M

TLSI$13M

Current Ratio (TTM)

MGNX2.96x

TLSI5.35x

Quick Ratio (TTM)

MGNX2.92x

TLSI4.72x

Debt/Equity (TTM)

MGNX4.16x

TLSI5.05x

Debt/Assets (TTM)

MGNX0.0%

TLSI0.0%

Interest Coverage (TTM)

MGNXN/A

TLSIN/A

Net Debt/EBITDA (TTM)

MGNX0.00x

TLSI0.00x

Beta

MGNX1.25

TLSI0.46

52W Performance

MGNX110.1%

TLSI-16.3%

YTD Performance

MGNX132.3%

TLSI-33.4%

% from 52W High

MGNX-26.4%

TLSI-48.9%

% from 52W Low

MGNX189.9%

TLSI84.5%

Asset Turnover (TTM)

MGNX0.61x

TLSI0.88x

FCF Yield (TTM)

MGNX-27.6%

TLSI-9.3%

Earnings Yield (TTM)

MGNX-6.1%

TLSI-23.5%

Dividend Yield (TTM)

MGNXN/A

TLSIN/A

Rule of 40

MGNX-37.8

TLSI-26.4

EV/GP/RG

MGNXN/A

TLSI0.11

Ticker research

View MGNX research View TLSI research

Metric	MGNX MacroGenics Inc	TLSI TriSalus Life Sciences Inc
Market & Valuation
Market Cap	$238M	$249M
Enterprise Value	$302M	$236M
Price	$3.74	$4.06
P/E Ratio	N/A	N/A
P/S Ratio	1.42x	5.53x
EV/Sales	1.80x	5.24x
EV/EBITDA	5.31x	0.00x
P/B Ratio	5.32x	40.61x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.61x	-10.14x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	2.39x	3.61x
Revenue & Growth
Revenue (TTM)	$168M	$45M
Revenue Growth (YoY)	1.3%	25.2%
Forward Rev Growth	-12.8%	40.1%
Profitability
Gross Margin (TTM)	61.8%	85.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-20.8%	-66.4%
Net Margin (TTM)	-8.7%	-130.2%
FCF Margin (TTM)	-39.1%	-51.6%
Net Income (TTM)	$-15M	$-59M
FCF (TTM)	$-66M	$-23M
EPS (TTM)	-$0.23	-$1.01
ROE (TTM)	-3127.0%	-7902.0%
ROA (TTM)	-535.0%	-5499.0%
ROIC (TTM)	-1017.0%	-1789.0%
Financial Health
Cash	$114M	$46M
Debt	$178M	$33M
Net Cash/Debt	$-64M	$13M
Current Ratio (TTM)	2.96x	5.35x
Quick Ratio (TTM)	2.92x	4.72x
Debt/Equity (TTM)	4.16x	5.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.25	0.46
52W Performance	110.1%	-16.3%
YTD Performance	132.3%	-33.4%
% from 52W High	-26.4%	-48.9%
% from 52W Low	189.9%	84.5%
Efficiency & Yields
Asset Turnover (TTM)	0.61x	0.88x
FCF Yield (TTM)	-27.6%	-9.3%
Earnings Yield (TTM)	-6.1%	-23.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-37.8	-26.4
EV/GP/RG	N/A	0.11
Ticker research	View MGNX research	View TLSI research

Valuation

P/S Ratio

MGNX

1.42x

TLSI

5.53x

EV/FCF

TLSI

-10.14x

MGNX

-4.61x

Growth & revenue

Revenue Growth TTM

TLSI

25.2%

MGNX

1.3%

Forward Revenue Growth

TLSI

40.1%

MGNX

-12.8%

Profitability & performance

Gross Margin

TLSI

85.8%

MGNX

61.8%

ROE

MGNX

-3127.0%

TLSI

-7902.0%

FCF Yield %

TLSI

-9.3%

MGNX

-27.6%

52-Week Performance

MGNX

110.1%

TLSI

-16.3%

Detailed metrics comparison

MGNX

MacroGenics Inc

TLSI

TriSalus Life Sciences Inc

Market Cap

MGNX$238M

TLSI$249M

Enterprise Value

MGNX$302M

TLSI$236M

Price

MGNX$3.74

TLSI$4.06

P/E Ratio

MGNXN/A

TLSIN/A

P/S Ratio

MGNX1.42x

TLSI5.53x

EV/Sales

MGNX1.80x

TLSI5.24x

EV/EBITDA

MGNX5.31x

TLSI0.00x

P/B Ratio

MGNX5.32x

TLSI40.61x

P/FCF Ratio

MGNXN/A

TLSIN/A

EV/FCF

MGNX-4.61x

TLSI-10.14x

PEG Ratio

MGNXN/A

TLSIN/A

Forward P/E (NTM)

MGNXN/A

TLSIN/A

Forward P/S (NTM)

MGNX2.39x

TLSI3.61x

Revenue (TTM)

MGNX$168M

TLSI$45M

Revenue Growth (YoY)

MGNX1.3%

TLSI25.2%

Forward Rev Growth

MGNX-12.8%

TLSI40.1%

Gross Margin (TTM)

MGNX61.8%

TLSI85.8%

Operating Margin (TTM)

MGNX0.0%

TLSI0.0%

EBITDA Margin (TTM)

MGNX-20.8%

TLSI-66.4%

Net Margin (TTM)

MGNX-8.7%

TLSI-130.2%

FCF Margin (TTM)

MGNX-39.1%

TLSI-51.6%

Net Income (TTM)

MGNX$-15M

TLSI$-59M

FCF (TTM)

MGNX$-66M

TLSI$-23M

EPS (TTM)

MGNX-$0.23

TLSI-$1.01

ROE (TTM)

MGNX-3127.0%

TLSI-7902.0%

ROA (TTM)

MGNX-535.0%

TLSI-5499.0%

ROIC (TTM)

MGNX-1017.0%

TLSI-1789.0%

Cash

MGNX$114M

TLSI$46M

Debt

MGNX$178M

TLSI$33M

Net Cash/Debt

MGNX$-64M

TLSI$13M

Current Ratio (TTM)

MGNX2.96x

TLSI5.35x

Quick Ratio (TTM)

MGNX2.92x

TLSI4.72x

Debt/Equity (TTM)

MGNX4.16x

TLSI5.05x

Debt/Assets (TTM)

MGNX0.0%

TLSI0.0%

Interest Coverage (TTM)

MGNXN/A

TLSIN/A

Net Debt/EBITDA (TTM)

MGNX0.00x

TLSI0.00x

Beta

MGNX1.25

TLSI0.46

52W Performance

MGNX110.1%

TLSI-16.3%

YTD Performance

MGNX132.3%

TLSI-33.4%

% from 52W High

MGNX-26.4%

TLSI-48.9%

% from 52W Low

MGNX189.9%

TLSI84.5%

Asset Turnover (TTM)

MGNX0.61x

TLSI0.88x

FCF Yield (TTM)

MGNX-27.6%

TLSI-9.3%

Earnings Yield (TTM)

MGNX-6.1%

TLSI-23.5%

Dividend Yield (TTM)

MGNXN/A

TLSIN/A

Rule of 40

MGNX-37.8

TLSI-26.4

EV/GP/RG

MGNXN/A

TLSI0.11

Ticker research

View MGNX research View TLSI research

Metric	MGNX MacroGenics Inc	TLSI TriSalus Life Sciences Inc
Market & Valuation
Market Cap	$238M	$249M
Enterprise Value	$302M	$236M
Price	$3.74	$4.06
P/E Ratio	N/A	N/A
P/S Ratio	1.42x	5.53x
EV/Sales	1.80x	5.24x
EV/EBITDA	5.31x	0.00x
P/B Ratio	5.32x	40.61x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.61x	-10.14x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	2.39x	3.61x
Revenue & Growth
Revenue (TTM)	$168M	$45M
Revenue Growth (YoY)	1.3%	25.2%
Forward Rev Growth	-12.8%	40.1%
Profitability
Gross Margin (TTM)	61.8%	85.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-20.8%	-66.4%
Net Margin (TTM)	-8.7%	-130.2%
FCF Margin (TTM)	-39.1%	-51.6%
Net Income (TTM)	$-15M	$-59M
FCF (TTM)	$-66M	$-23M
EPS (TTM)	-$0.23	-$1.01
ROE (TTM)	-3127.0%	-7902.0%
ROA (TTM)	-535.0%	-5499.0%
ROIC (TTM)	-1017.0%	-1789.0%
Financial Health
Cash	$114M	$46M
Debt	$178M	$33M
Net Cash/Debt	$-64M	$13M
Current Ratio (TTM)	2.96x	5.35x
Quick Ratio (TTM)	2.92x	4.72x
Debt/Equity (TTM)	4.16x	5.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.25	0.46
52W Performance	110.1%	-16.3%
YTD Performance	132.3%	-33.4%
% from 52W High	-26.4%	-48.9%
% from 52W Low	189.9%	84.5%
Efficiency & Yields
Asset Turnover (TTM)	0.61x	0.88x
FCF Yield (TTM)	-27.6%	-9.3%
Earnings Yield (TTM)	-6.1%	-23.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-37.8	-26.4
EV/GP/RG	N/A	0.11
Ticker research	View MGNX research	View TLSI research